Abstract
The limitations associated with using biologically-based mathematical models for the estimation of carcinogenic risks from long-term chemical exposures at low dose levels represents a statistical and mathematical challenge with special relevance to environmental research. Determining an adequate model for estimating the relationship between dose and response is critical to reducing potential bias in the risk estimation process. This talk discusses the various assumptions and models used in carcinogenic risk assessment. The emphasis will be on the accuracy with which the magnitude of the carcinogenic risk, the shape of the dose-response relationship and the overall variability of the risk estimates can be determined from the available data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen, M., Clewell, H., Gargas, F., Smith, F., and Reitz, R. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicology and Applied Pharmacology 87: 185–202.
Anderson, E. and the Carcinogen Assessment Group (1983). Quantitative approaches in use to assess cancer risk. Risk Analysis 3: 277–295.
Anderson, M. (1987). Issues in biochemical applications to risk assessment: How do we evaluate individual components of multistage models? Environmental Health Perspectives 76, 175–180.
Armitage, P. and Doll, R. (1954). The age distribution of cancer and a multistage theory of cancer. British Journal of Cancer 8: 1–12.
Barrett, J. C. and Wiseman, R. (1987). Cellular and molecular mechanisms of multistep carcinogenesis: Relevance to carcinogen risk assessment. Environmental Health Perspectives 76, 65–70.
Barrett, J. C. and Wiseman, R. W. (1989). Relevance of Cellulart and Molecular Mechanisms of Multistep Carcinogenesis to Risk Assessment, (unpublished manuscript).
Bogen, K. (1989). Cell proliferation kinetics and multistage cancer risk models. Journal of the National Cancer Institute 81, 267–277
EPA (1986). Guidelines for carcinogen risk assessment. 51 Federal Register 33992, 1–17.
Farber, E. (1984). Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Research 44: 5463–5474.
Hoel, D., Kaplan, N. and Anderson, M. (1983). Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science 219: 1032–1037.
Hoel, D. (1980). Incorporation of background in dose-response models. Federation Proceedings 39: 73–75.
Kopp, A. and Portier, C. (1989). A note on approximating the cumulative distribution function of the time to tumor onset in multistage models, (unpublished manuscript).
Lewis, J. and Adams, D. (1987). Inflammation, oxidative DNA damage and carcinogenesis. Environmental Health Perspectives 76, 19–28.
Moolgavkar, S. (1983). Model for human carcinogenesis: Action of environmental agents. Environmental Health Perspectives 50: 285–291.
Moolgavkar, S., Dewanji, A., and Venzon, D. (1988). A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Analysis 8 (3), 383–392.
Moolgavkar, S. and Dewanji, A. (1988). Biologically based models for cancer risk assessment: A cautionary note. Risk Analysis 8(1), 5–6.
Pitot, H., Barsness, L. and Kitagawa, T. (1978). Stages in the process of hepatocarcinogenesis in rat liver. Carcinogenesis 2: 433–442.
Portier, C. (1987). Statistical properties of a two-stage model of carcinogenesis. Environmental Health Perspectives 76: 125–131.
Portier, C. and Kaplan, N. (1989). The variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: Methylene chloride. Fundamental and Applied Toxicology 13, 533–544.
Portier, C. (1989). Quantitative risk assessment. In Ragsdale, N. and Menzer, R. (eds.): Carcinogenicity and Pesticides. American Chemical Society Symposium Series Number 414; (to appear).
Portier, C., Hoel, D., Kaplan, N. and Kopp, A. (1990) Biologically based models for risk assessment. In H. Vannio, M. Sorsa and A. J. McMichael (eds) Complex Mixtures and Cancer Risk. IARC Scientific Publications Number 104, International Agency for Research on Cancer, Lyon (to appear).
Portier, C. and Edler, L. (1989) Two-stage models of carcinogenesis, classification of agents and design of experiments, (submitted)
Prehn, R. (1964). A clonal selection theory of chemical carcinogenesis. Journal of the National Cancer Institute 32 (1): 1–17.
Reynolds, S., Stowers, S., Patterson, R., Maronpot, R., Aaronson, S. and Anderson, M. (1987). Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science 237, 1309–1316.
Sakata, T., Masui, T., St. John, M. and Cohen, S. (1988). Uracil-induced calculi and proliferative lesions of the mouse urinary bladder. Carcinogenesis 9 (7), 1271–1276.
Schwartz, M., Pearson, D., Port, R. and Kunz, W. (1984). Promoting effect of 4-dimethylaminoazobenzene on enzyme altered foci in rat liver by N-nitrosodiethanolamine. Carcinogenesis 5: 725–730.
Swenberg, J., Richardson, F., Boucheron, J. and Dryoff, M. (1985). Relationships between DNA adduct formation and carcinogenesis. Environmental Health Perspectives 62: 177–183.
Swenberg, J., Richardson, F., Boucheron, J., Deal, F., Belinsky, S., Charbonneau, M. and Short, B. (1987). High to low dose extrapolation: Critical determinants involved in the dose response of carcinogenic substances. Environmental Health Perspectives 76, 57–63.
Thorslund, T., Brown, C. and Charnley, G. (1987). Biologically motivated cancer risk models. Risk Analysis 7: 109–119.
Travis, C. and White, R. (1988). Interspecies scaling of toxicity data. Risk Analysis 8, 119–125.
Whittemore, A. and Keller, J. (1978). Quantitative theories of carcinogenesis. SIAM Review 20, 1–30.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Birkhäuser Boston
About this chapter
Cite this chapter
Portier, C.J. (1990). Utilizing Biologically Based Models to Estimate Carcinogenic Risk. In: Moolgavkar, S.H. (eds) Scientific Issues in Quantitative Cancer Risk Assessment. Birkhäuser Boston. https://doi.org/10.1007/978-1-4684-9218-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9218-7_14
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4684-9220-0
Online ISBN: 978-1-4684-9218-7
eBook Packages: Springer Book Archive